Skip to main content

Table 4 Sensitivity, specificity, positive- and negative predictive value and area under the curve for prediction of Rivaroxaban plasma concentration > 50 ng/mL

From: Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban

 

N > 50 ng/mL

Sensitivity

(95% CI)

Specificity

(95% CI)

PPV

NPV

AUC

(95% CI)

LC-MS/MS

223

0.9776

(0.9485–0.9927)

0.7727

(0.6917–0.8411)

0.3912

0.9957

0.9866

(0.9785–0.9947)

Anti-FXa

216

0.7554

(0.6753–0.8243)

0.9907

(0.9670–0.9989)

0.9239

0.9644

0.9929

(0.9876–0.9982)

  1. Number of samples (N), Positive predictive value (PPT), Negative predictive value (NPV), Area under the Curve (AUC).
Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us